OSUR
NASD OraSure Technologies, Inc.$4.01 ↑ +0.09 (+2.30%) Trading Up from the previous close of $3.92
- YTD change
- +65.70%
- vs 20-day SMA
- +5.14%
- vs 200-day SMA
- +17.33%
Price ranges
Price & Performance
+0.84 (+27.27%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 82.6% away from all-time highs of $23.01
- OSUR is up 66% since the beginning of the year
- OSUR is up 33% over the past 12 months
- OSUR is up 19% over the past 1 month
- 4% of all OSUR investors are betting against OSUR
OSUR reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +30.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.17
- Last 5 days
- -2.43%
- vs 8-day SMA
- +3.25%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
